Betaliq
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
905 E Martin Luther King Jr Dr Ste 240, ...Phone Number
(813) 766-9539Website
www.betaliq.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Betaliq
Betaliq Inc. is a clinical-stage pharmaceutical company focused on innovating glaucoma treatments through advanced technology and patient-centric solutions. Established in 2018, the company utilizes the proprietary EyeSol technology to enhance the efficacy and safety of topical ophthalmic therapies. Their lead product, BTQ1902, is a timolol suspension designed to improve treatment outcomes for glaucoma patients, with promising results from Phase 2 clinical trials. Betaliq aims to address significant unmet needs in eye care and expand its portfolio into other areas of ophthalmology.Explore more
Popular SearchesBetaliq IncBetaliqSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Betaliq your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Betaliq has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Betaliq
Earning: See what the market has to say on Betaliq recently announced quarterly report
Click to see if Betaliq had a recent Job posting/layoffs
Check out if Betaliq is spiking on competitors!
Funding: Get notified immidiatlly once Betaliq has new funding data
Betaliq, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Betaliq launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Betaliq
Compare insights from companies similar to Betaliq, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Betaliq
<$5M
11-50
Private
-
2018
N/A
Company Profile Activity
Activity Insights
Betaliq is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Betaliq is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Betaliq.
Betaliq Tech Stack
A closer look at the technologies used by Betaliq
See more technologies
Betaliq News & Media
Eyenovia Advances Betaliq Merger Talks, Plans FDA Filing for Optejet Device - Stock Titan
Eyenovia extends merger talks with Betaliq, confirms September FDA filing for Optejet device, and cuts cash burn 70%. See full strategic transformation details.Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results
Eyenovia and Betaliq continue to negotiate a binding merger agreement consistent with the previously announced signed Letter of IntentEyenovia, Betaliq enter potential reverse merger agreement - Optometry Times
If executed, the reverse merger would create a new ophthalmic company that pairs two FDA-approved technologies for use in glaucoma patients.Eyenovia Shares Drop 14% Amid Betaliq Merger Talks
The proposed deal values Betaliq at $77 million and Eyenovia at $15 million.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Betaliq
Sign Up For FreeTo access detailed company insights
Betaliq Inc. is a clinical-stage pharmaceutical company focused on innovating glaucoma treatments through advanced technology and patient-centric solutions. Established in 2018, the company utilizes the proprietary EyeSol technology to enhance the efficacy and safety of topical ophthalmic therapies. Their lead product, BTQ1902, is a timolol suspens... Read More
